Convergence Investment Partners’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-11,286
| Closed | -$519K | – | 347 |
|
|
2018
Q3 | $519K | Sell |
11,286
-28,177
| -71% | -$1.3M | 0.11% | 214 |
|
|
2018
Q2 | $1.48M | Sell |
39,463
-84,264
| -68% | -$3.15M | 0.21% | 145 |
|
|
2018
Q1 | $3.66M | Buy |
123,727
+13,450
| +12% | +$397K | 0.48% | 67 |
|
|
2017
Q4 | $3.79M | Buy |
+110,277
| New | +$3.79M | 0.51% | 65 |
|
|
2017
Q3 | – | Sell |
-59,770
| Closed | -$1.54M | – | 373 |
|
|
2017
Q2 | $1.54M | Sell |
59,770
-18,808
| -24% | -$486K | 0.23% | 176 |
|
|
2017
Q1 | $1.51M | Buy |
78,578
+62,200
| +380% | +$1.19M | 0.21% | 185 |
|
|
2016
Q4 | $273K | Sell |
16,378
-103,813
| -86% | -$1.73M | 0.04% | 291 |
|
|
2016
Q3 | $2.47M | Buy |
120,191
+13,064
| +12% | +$269K | 0.37% | 94 |
|
|
2016
Q2 | $3.28M | Buy |
107,127
+55,941
| +109% | +$1.71M | 0.45% | 78 |
|
|
2016
Q1 | $1.92M | Sell |
51,186
-74,978
| -59% | -$2.81M | 0.23% | 155 |
|
|
2015
Q4 | $5.45M | Buy |
+126,164
| New | +$5.45M | 0.61% | 31 |
|
|
2015
Q1 | – | Sell |
-47,424
| Closed | -$1.62M | – | 395 |
|
|
2014
Q4 | $1.62M | Sell |
47,424
-21,668
| -31% | -$738K | 0.22% | 163 |
|
|
2014
Q3 | $2.67M | Hold |
69,092
| – | – | 0.37% | 97 |
|
|
2014
Q2 | $2.69M | Buy |
69,092
+18,280
| +36% | +$711K | 0.35% | 97 |
|
|
2014
Q1 | $1.74M | Sell |
50,812
-73,791
| -59% | -$2.52M | 0.26% | 126 |
|
|
2013
Q4 | $2.61M | Buy |
124,603
+38,204
| +44% | +$801K | 0.42% | 73 |
|
|
2013
Q3 | $2.03M | Buy |
86,399
+26,351
| +44% | +$619K | 0.43% | 90 |
|
|
2013
Q2 | $1.61M | Buy |
+60,048
| New | +$1.61M | 0.42% | 89 |
|